Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)
7.40
+0.40
(+5.71%)
USD |
OTCM |
May 07, 15:49
Shanghai Pharmaceuticals Debt to Equity Ratio: 0.6794 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.6794 |
| December 31, 2023 | 0.6466 |
| September 30, 2023 | 0.6643 |
| June 30, 2023 | 0.6655 |
| March 31, 2023 | 0.6278 |
| December 31, 2022 | 0.5556 |
| September 30, 2022 | 0.5705 |
| June 30, 2022 | 0.5798 |
| March 31, 2022 | 0.5461 |
| December 31, 2021 | 0.6129 |
| September 30, 2021 | 0.69 |
| June 30, 2021 | 0.6696 |
| March 31, 2021 | 0.6867 |
| December 31, 2020 | 0.6679 |
| September 30, 2020 | 0.7016 |
| June 30, 2020 | 0.7782 |
| March 31, 2020 | 0.833 |
| December 31, 2019 | 0.8032 |
| September 30, 2019 | 0.7716 |
| June 30, 2019 | 0.7774 |
| March 31, 2019 | 0.7865 |
| December 31, 2018 | 0.816 |
| September 30, 2018 | 0.7904 |
| June 30, 2018 | 0.7574 |
| March 31, 2018 | 0.7138 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.4926 |
| September 30, 2017 | 0.4691 |
| June 30, 2017 | 0.4766 |
| March 31, 2017 | 0.4655 |
| December 31, 2016 | 0.3948 |
| September 30, 2016 | 0.3665 |
| June 30, 2016 | 0.3635 |
| March 31, 2016 | 0.36 |
| December 31, 2015 | 0.3599 |
| September 30, 2015 | 0.3333 |
| June 30, 2015 | 0.3288 |
| March 31, 2015 | 0.2915 |
| December 31, 2014 | 0.2896 |
| September 30, 2014 | 0.2795 |
| June 30, 2014 | 0.2751 |
| March 31, 2014 | 0.2433 |
| December 31, 2013 | 0.2331 |
| September 30, 2013 | 0.2142 |
| June 30, 2013 | 0.2052 |
| March 31, 2013 | 0.1917 |
| December 31, 2012 | 0.2006 |
| September 30, 2012 | 0.204 |
| June 30, 2012 | 0.232 |
| March 31, 2012 | 0.2338 |
| December 31, 2011 | 0.2482 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5461
Minimum
Mar 2022
0.833
Maximum
Mar 2020
0.6764
Average
0.6687
Median
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0517 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 30.55B |
| Total Liabilities (Quarterly) | 19.02B |
| Shareholders Equity (Quarterly) | 9.845B |
| Current Ratio | 1.336 |
| Net Debt Paydown Yield | -4.78% |